Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US PTO's Patent Eligibility Guidance Draws Industry Plaudits, Request For More Specifics

Apr 17 2019

• By Brenda Sandburg

3D illustration/ 3D rendering - Subject matter concept — Guidance Helps Clarify How PTO Examiners Should Assess An Invention's Eligibility For Patenting

Related Content

Federal Circuit Tosses Diagnostic Patent, Spurring Biopharma Calls For Congressional Action

Feb 08 2019

FTC Hearing On IP Policy: Patent Eligibility Requirements Are Top Industry Concern

Oct 28 2018

Bill To Revise US Subject Matter Patent Eligibility Standard Expected By 'Early Summer'

Mar 13 2019

Related Companies

Prometheus Laboratories Inc.

Novartis AG

Vanda Pharmaceuticals, Inc.

Hikma Pharmaceuticals plc

Quest Diagnostics Incorporated

Amgen, Inc.

Genentech, Inc.

Sequenom, Inc.

Additional Topics

United States Intellectual Property Legal Issues Policy BioPharmaceutical

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window